Outlook Therapeutics Overview
Outlook Therapeutics Discounted Cash Flow
DCF Analysis for OTLK.
Get informed when a big investor buys or sells
+ FollowFair Value
$-0.19
Current Fair Value
$-0.19
↓ 116.1% Downside
Overvalued by 116.1% based on the discounted cash flow analysis.
Average Upside/Downside (Comparison Companies)
Fair Value vs. Stock Price History
Upside/Downside History
Upside/Downside Comparison